Sign In
Buy ENTG
$140.33
-2.59 (-1.81%)
At Close: Jun 03, 2026
Entourage Health Announces Canadian Debut of The Boston Beer Company’s New Cannabis-Infused Iced Tea Beverages ‘TeaPot’
11:40am, Tuesday, 24'th May 2022 GlobeNewswire Inc.
Available mid-summer 2022 in select provinces, TeaPot is first non-alcoholic, infused beverage crafted in partnership with Boston Beer’s cannabis subsidiary BBCCC Inc. and Peak Processing Available
Entourage Health Reaffirms First Quarter 2022 Preliminary Record Revenues of $17.4 Million and Announces Financial Results Call to be held on May 31, 2022
11:30am, Friday, 20'th May 2022 GlobeNewswire Inc.
Q1 financial filings expected after-market May 30, with management conference call following day Q1 financial filings expected after-market May 30, with management conference call following day
Entourage Health Enters into Voting Support Agreement and Announces Proposed Amendments to its 8.5% Unsecured Convertible Debentures
12:22pm, Friday, 13'th May 2022 GlobeNewswire Inc.
Company looks to improve capital structure and create long-term value for all security holders Company looks to improve capital structure and create long-term value for all security holders
Entegris: Beneficial 2022 Guidance And A Lot Of Recurrent Sales Make It Undervalued
05:56am, Thursday, 12'th May 2022
Entegris runs a micro contamination control division, especially chemical engineering and advanced materials handling segments. The most interesting features, in my view, are the company's recurring r
Entourage Health to Present at the Canaccord Genuity 6th Annual Global Cannabis Virtual Conference on May 11th
03:36pm, Tuesday, 10'th May 2022 GlobeNewswire Inc.
TORONTO, May 10, 2022 (GLOBE NEWSWIRE) -- Entourage Health Corp. (formerly WeedMD Inc.) (TSX-V:ENTG) (OTCQX:ETRGF) (FSE:4WE) (“Entourage” or the “Company”), a Canadian producer and distribut
Entourage Reports Record Fiscal Year 2021 Financial Results with $55.2 Million in Total Revenue for a 56% Year-Over-Year Increase and Preliminary Q1 2022 Record Revenue of $17.4 Million
02:49pm, Monday, 09'th May 2022 GlobeNewswire Inc.
TORONTO, May 09, 2022 (GLOBE NEWSWIRE) -- Entourage Health Corp. (formerly WeedMD Inc.) (TSX-V:ENTG) (OTCQX:ETRGF) (FSE:4WE) (“Entourage” or the “Company”), a Canadian producer and distribut
Entourage Health Announces Issuance of Cease Trade Order
01:30pm, Monday, 09'th May 2022 GlobeNewswire Inc.
Company confirms audit procedures and Annual Filings completed on May 9, 2022, and anticipates CTO to be revoked with trading of its common shares to resume in the coming days Company confirms audit p
Entourage Health Partners with Pineapple Express to Provide Same-Day Medical Cannabis Delivery Service to its Starseed Medicinal Patients
11:46am, Wednesday, 04'th May 2022 GlobeNewswire Inc.
Company’s upgraded medical delivery services available to its clients effective mid-May 2022 Company’s upgraded medical delivery services available to its clients effective mid-May 2022
Entourage Health Reschedules Full-Year 2021 Earnings Release and Conference Call to Align with First Quarter 2022 Results
11:06am, Tuesday, 03'rd May 2022 GlobeNewswire Inc.
Company reaffirms previously announced full-year 2021 preliminary revenue with further improvements at $55.2 million(1) and preliminary gross margins of 7.0%(1) for the year
Should Vanguard SmallCap Growth ETF (VBK) Be on Your Investing Radar?
10:20am, Monday, 02'nd May 2022 Zacks Investment Research
Style Box ETF report for VBK
Entourage Health and LiUNA Pension Fund Upsize Credit Facility with Additional $15 Million in Funding Availability
05:58pm, Friday, 29'th Apr 2022 GlobeNewswire Inc.
TORONTO, April 29, 2022 (GLOBE NEWSWIRE) -- Entourage Health Corp. (formerly WeedMD Inc.) (TSX-V:ENTG) (OTCQX:ETRGF) (FSE:4WE) (“Entourage” or the “Company”), a Canadian producer and distrib
Here is Why Growth Investors Should Buy Entegris (ENTG) Now
04:45pm, Thursday, 28'th Apr 2022 Zacks Investment Research
Entegris (ENTG) could produce exceptional returns because of its solid growth attributes.
Entegris (ENTG) Upgraded to Buy: What Does It Mean for the Stock?
04:00pm, Thursday, 28'th Apr 2022 Zacks Investment Research
Entegris (ENTG) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Here is Why Growth Investors Should Buy Entegris (ENTG) Now
02:17pm, Thursday, 28'th Apr 2022
Entegris (ENTG) could produce exceptional returns because of its solid growth attributes.
